{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T02:26:11Z","timestamp":1776133571193,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.ejogrb.2004.06.035","type":"journal-article","created":{"date-parts":[[2004,12,15]],"date-time":"2004-12-15T15:20:06Z","timestamp":1103124006000},"page":"209-213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Combined use of metformin and ethinyl estradiol\u2013cyproterone acetate in polycystic ovary syndrome"],"prefix":"10.1016","volume":"118","author":[{"given":"M.","family":"Mitkov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Pehlivanov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Terzieva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2004.06.035_bib1","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199509283331307","article-title":"Polycystic ovary syndrome","volume":"333","author":"Franks","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2004.06.035_bib2","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1016\/S0002-9378(98)70238-8","article-title":"Polycystic ovary syndrome: symptomatology, pathophysiology, and epidemiology","volume":"179","author":"Guzick","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2004.06.035_bib3","first-page":"774","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanisms and implications for pathogenesis","volume":"18","author":"Dunaif","year":"1997","journal-title":"Endocrine Rev"},{"key":"10.1016\/j.ejogrb.2004.06.035_bib4","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/00003081-200306000-00011","article-title":"Insulin sensitizers for polycystic ovary syndrome","volume":"46","author":"Baillargeon","year":"2003","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2004.06.035_bib5","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0029-7844(97)00296-2","article-title":"Menstrual cyclicity after metformin therapy in polycystic ovary syndrome","volume":"90","author":"Velazquez","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2004.06.035_bib6","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1034\/j.1600-0412.2001.080008689.x","article-title":"Clinical management of PCOS","volume":"80","author":"Tan","year":"2001","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ejogrb.2004.06.035_bib7","first-page":"139","article-title":"Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized double-blind, placebo-controlled 6-month trial followed by open, long-term clinical evaluation","volume":"85","author":"Moghetti","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2004.06.035_bib8","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/bmj.327.7421.951","article-title":"Metformin in polycystic ovary syndrome: systematic review and meta-analysis","volume":"327","author":"Lord","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.ejogrb.2004.06.035_bib9","doi-asserted-by":"crossref","unstructured":"The Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome, Fertil Steril 2004;81:19\u201325.","DOI":"10.1016\/j.fertnstert.2003.10.004"},{"key":"10.1016\/j.ejogrb.2004.06.035_bib10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/humrep\/deg056","article-title":"Low-dose combination of flutamide, metformin and an oral contraceptive for non-obese, young women with polycystic ovary syndrome","volume":"18","author":"Ib\u00e1\u00f1ez","year":"2003","journal-title":"Human Reprod"},{"key":"10.1016\/j.ejogrb.2004.06.035_bib11","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1093\/humrep\/17.7.1729","article-title":"Clinical endocrine and metabolic effects of metformin added to ethinyl estradiol\u2013cyproterone acetate in non-obese women with polycystic ovary syndrome: a randomized controlled study","volume":"17","author":"Elter","year":"2002","journal-title":"Human Reprod"},{"key":"10.1016\/j.ejogrb.2004.06.035_bib12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7326\/0003-4819-137-1-200207020-00009","article-title":"Metformin: an update","volume":"137","author":"Kirpichnikov","year":"2002","journal-title":"Ann Int Med"},{"key":"10.1016\/j.ejogrb.2004.06.035_bib13","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1210\/jc.2002-020997","article-title":"Metformin versus ethinyl estradiol\u2013cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized study","volume":"88","author":"Morin-Papunen","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2004.06.035_bib14","first-page":"3161","article-title":"Endocrine and metabolic effects of metformin versus ethinyl estradiol\u2013cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study","volume":"85","author":"Morin-Papunen","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2004.06.035_bib15","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1093\/humrep\/17.12.3016","article-title":"Should patients with polycystic ovary syndrome be treated with metformin?","volume":"17","author":"Stadtmauer","year":"2002","journal-title":"Human Reprod"},{"key":"10.1016\/j.ejogrb.2004.06.035_bib16","series-title":"Androgen Excess Disorders in Women","first-page":"787","article-title":"Treatment of hirsutism Antiandrogen and 5-\u03b1-reductase inhibitor therapy","author":"Fruzetti","year":"1997"},{"key":"10.1016\/j.ejogrb.2004.06.035_bib17","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1093\/humrep\/17.8.1950","article-title":"Should patients with polycyctic ovary syndrome be treated with metformin? An enthusiastic endorsement","volume":"17","author":"Nestler","year":"2002","journal-title":"Human Reprod"},{"key":"10.1016\/j.ejogrb.2004.06.035_bib18","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1210\/jc.2002-021528","article-title":"A modern medical quandary: polycystic ovary syndrome, insulin resistance, and oral contraceptive pills","volume":"88","author":"Diamanti-Kandarakis","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2004.06.035_bib19","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1093\/humrep\/13.10.2706","article-title":"Effects of two antiandrogen treatments on hirsutism and insulin sensitivity in women with polycystic ovary syndrome","volume":"13","author":"Dahlgren","year":"1998","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2004.06.035_bib20","first-page":"3327","article-title":"Metabolic effects of oral contraceptives in women with polycystic ovary syndrome","volume":"80","author":"Korytkowski","year":"1995","journal-title":"J Clin Endocrinol Metab"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211504003756?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211504003756?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:12:49Z","timestamp":1759554769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211504003756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S0301211504003756"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2004.06.035","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined use of metformin and ethinyl estradiol\u2013cyproterone acetate in polycystic ovary syndrome","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2004.06.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}